FentaNYL 0.4 mg/ACTUAT
RxNorm 1115576
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1115576 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: fentaNYL 0.4 mg/ACTUAT.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
FentaNYL 0.4 mg/ACTUAT
(Atom ID: 3747393)
SCDCPrescribable
Semantic Clinical Drug Component (SCDC):
Fentanyl 0.4 mg/ACTUAT
(Atom ID: 12267569)
Patient Education
Fentanyl Nasal Spray
Fentanyl nasal spray is used to treat breakthrough pain (sudden episodes of pain that occur despite round the clock treatment with pain medication) in cancer patients 18 years of age or older who are taking regularly scheduled doses of another narcotic (opiate) pain medication, and who are tolerant (used to the effects of the medication) to narcotic pain medications. Fentanyl is in a class of medications called narcotic (opiate) analgesics. It works by changing the way the brain and nervous system respond to pain.
[Learn More]
Fentanyl Sublingual Spray
Fentanyl sublingual spray is used to treat breakthrough pain (sudden episodes of pain that occur despite round the clock treatment with pain medication) in cancer patients 18 years of age and older who are taking regularly scheduled doses of another narcotic (opiate) pain medication, and who are tolerant (used to the effects of the medication) to narcotic pain medications. Fentanyl is in a class of medications called narcotic (opiate) analgesics. It works by changing the way the brain and nervous system respond to pain.
[Learn More]
* Please review the disclaimer below.